United Therapeutics UTHR Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's total cost of revenue?
- United Therapeutics (UTHR) reported total cost of revenue of $133.4M in Q1 2026.
- How has United Therapeutics's total cost of revenue changed year-over-year?
- United Therapeutics's total cost of revenue increased by 44.2% year-over-year, from $92.5M to $133.4M.
- What is the long-term trend for United Therapeutics's total cost of revenue?
- Over 4 years (2021 to 2025), United Therapeutics's total cost of revenue has grown at a 33.1% compound annual growth rate (CAGR), from $122.5M to $384.4M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.